The Efficacy of Adductor-Canal-Block (ACB) in Patients After Knee Arthroscopy

Glostrup University Hospital, Copenhagen

Status and phase: Completed; Phase 4

Conditions: Pain (Knee); Minor Knee Surgery; Meniscus Lesion; Diagnostic Knee Artroscopy

Treatments: Procedure: Adductor-Canal-Block, Ropivacain; Procedure: Adductor Canal Block, Placebo (saline)

Study type: Interventional

Funder types: Other

Identifiers

NCT01254825

SM2-ME-10

Details and patient eligibility

About

The Purpose of this study is to determine whether Adductor-Canal-Block (ACB) is superior to placebo when it comes to analgetic efficacy after Knee-Arthroscopy.

Enrollment: 72 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18-80 years
• Knee-arthroscopy
• Written consent
• ASA I-III
• BMI 19-35

Exclusion criteria

• Unable to communicate in Danish
• Allergic reactions toward drugs used in the trial
• Pregnancy
• Abuse of alcohol/drugs
• Daily opioid intake
• Infection at injection site
• Can not be mobilised to 5 meters of walk; pre-surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

72 participants in 2 patient groups, including a placebo group

Adductor-Canal-Block, Ropivacain

Experimental group

Description:

Adductor-Canal-Block, 30 mL Ropivacain 7,5 mg/mL. Single dose. Ultrasound-guided application. 36 patients

Treatment:

Procedure: Adductor-Canal-Block, Ropivacain

Adductor-Canal-Block (ACB) - Saline

Placebo Comparator group

Description:

Adductor-Canal-Block, Placebo (30 mL Saline). Ultrasound-guided application. 36 patients.

Treatment:

Procedure: Adductor Canal Block, Placebo (saline)